A chronic disorder characterized by motor abnormalities of the small and large intestines, causing variable symptoms including cramping, abdominal pain, constipation, and diarrhea. Also called irritable colon, spastic colon.
irritable bowel syndrome - recurrent abdominal pain and diarrhea (often alternating with periods of constipation); often associated with emotional stress
According to report published by Grand View Research, The global irritable bowel syndrome treatment market size was valued at USD 1.5 billion in 2018 and is anticipated to exhibit a CAGR of 10.1% over the forecast period.
Public health agency The US Food and Drug Administration announced on Friday that it authorised the marketing of the first medical device IB-Stim through the de novo premarket review pathway for the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome (IBS) when combined with other therapies for IBS.
Irritable bowel syndrome (IBS) is a functional disorder characterised with recurrent abdominal pain or discomfort which is associated with alterations in frequency or form of stool and improvement after defecation.9 IBS is highly prevalent, affecting nearly 20% of general population.
Ironwood Pharmaceuticals is commercialising two innovative primary care products: linaclotide for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), and lesinurad, which is approved to be taken with a xanthine oxidase inhibitor (XOI) for the treatment of hyperuricemia associated with uncontrolled gout.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.